Aravive Inc's filing for a mixed shelf offering of up to $250 million may impact its stock price in the short term. The offering could lead to dilution of existing shares, but it also provides the company with additional capital for growth and expansion. The overall impact on the stock price is uncertain, hence the neutral score.